Evogene Announces CFO Resignation and Finance Leadership Transition

Evogene ( (EVGN) ) has issued an announcement.

On January 15, 2026, Israel-based Evogene Ltd. reported a senior management change, announcing that Chief Financial Officer Yaron Eldad has submitted his resignation for personal reasons, effective March 31, 2026, with the company clarifying that his departure does not stem from any disagreement over its operations, policies or practices. VP Finance Polina Ravzin, who has held that position since 2022 and previously served in finance roles at DSIT Solutions Ltd. and Acorn Energy Inc., will retain her current role while also assuming the responsibilities of CFO, signaling continuity in Evogene’s financial leadership structure during the transition.

The most recent analyst rating on (EVGN) stock is a Buy with a $2.50 price target. To see the full list of analyst forecasts on Evogene stock, see the EVGN Stock Forecast page.

Spark’s Take on EVGN Stock

According to Spark, TipRanks’ AI Analyst, EVGN is a Neutral.

Evogene’s overall stock score is primarily impacted by its weak financial performance and poor valuation metrics. While the earnings call provided some positive insights into cost management and strategic initiatives, the company’s financial instability and bearish technical indicators weigh heavily on the score.

To see Spark’s full report on EVGN stock, click here.

More about Evogene

Evogene Ltd. is an Israel-based company listed in the United States, operating as a foreign private issuer under the Securities Exchange Act of 1934. The company is subject to SEC reporting requirements and maintains registration statements for the issuance of securities to investors and for equity-based compensation plans.

Average Trading Volume: 55,443

Technical Sentiment Signal: Sell

Current Market Cap: $9.15M

Find detailed analytics on EVGN stock on TipRanks’ Stock Analysis page.